← TG THERAPEUTICS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $25.0m | $56.7m | $42.0m | $112.6m | $553.4m | $298.9m | $102.3m | $92.9m | $179.9m | $79.1m | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | $140.4m | $605.4m | $350.3m | $174.1m | $217.5m | $311.0m | $199.5m | |
| Short-term Investments | $19.9m | $28.0m | $26.8m | $27.8m | $52.0m | $15.9m | $59.4m | $124.6m | $131.1m | $62.8m | |
| Inventory, Net | — | — | — | — | — | — | $0 | $39.8m | $110.5m | $125.6m | |
| Assets, Current | $50.9m | $93.3m | $79.0m | $149.2m | $611.7m | $331.0m | $168.3m | $317.9m | $566.4m | $630.8m | |
| Property, Plant and Equipment, Net | $328k | $248k | $251k | $282k | $481k | $600k | $307k | $95k | — | — | |
| Goodwill | $799k | $799k | $799k | $799k | $799k | $799k | $799k | $799k | — | — | |
| Operating Lease, Right-of-Use Asset | — | — | — | $9.4m | $9.3m | $8.6m | $8.9m | $8.1m | $7.2m | $6.3m | |
| Other Assets, Noncurrent | $164k | $0 | — | — | — | — | — | — | $2.1m | $2.0m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | — | — | $51.1m | $129.2m | $305.6m | |
| Assets | $54.8m | $97.4m | $83.6m | $163.0m | $625.6m | $379.6m | $193.6m | $329.6m | $577.7m | $1.1b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $1.6m | $1.7m | $1.4m | $1.6m | $1.4m | $1.2m | $1.0m | |
| Operating Lease, Liability, Noncurrent | — | — | $0 | $10.2m | $10.4m | $9.8m | $10.3m | $9.2m | $8.1m | $7.0m | |
| Deferred Revenue, Current | $152k | $152k | $152k | — | — | — | — | $152k | $11.4m | $21.2m | |
| Deferred Revenue, Noncurrent | $1.2m | $1.1m | $914k | $762k | $610k | $457k | $305k | $6.0m | $12.1m | $8.8m | |
| Long-term Debt, Current Maturities | — | — | — | $0 | $22.2m | $975k | $0 | — | — | — | |
| Long-term Debt, Excluding Current Maturities | — | — | — | $29.0m | $7.7m | $66.8m | $71.1m | $100.1m | $244.4m | $245.6m | |
| Liabilities, Current | $16.9m | $28.0m | $38.9m | $84.4m | $87.6m | $65.4m | $53.2m | $53.7m | $90.7m | $153.8m | |
| Other Liabilities, Noncurrent | — | — | $18.4m | $0 | — | — | — | — | — | — | |
| Liabilities | $18.9m | $30.4m | $59.6m | $124.4m | $106.3m | $142.5m | $135.0m | $169.1m | $355.3m | $415.2m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $143k | $146k | $151k | $156k | $159k | |
| Common Stock, Value, Issued | $57k | $73k | $84k | $109k | $141k | $143k | $146k | $151k | $156k | $159k | |
| Additional Paid in Capital | $272.4m | $422.0m | $552.5m | $740.0m | $1.5b | $1.6b | $1.6b | $1.7b | $1.8b | $1.8b | |
| Retained Earnings (Accumulated Deficit) | ($236.4m) | ($354.9m) | ($528.3m) | ($701.2m) | ($980.6m) | ($1.3b) | ($1.5b) | ($1.5b) | ($1.5b) | ($1.1b) | |
| Stockholders' Equity Attributable to Parent | — | — | — | — | — | — | — | $160.5m | $222.4m | $648.0m | |
| Liabilities and Equity | $54.8m | $97.4m | $83.6m | $163.0m | $625.6m | $379.6m | $193.6m | $329.6m | $577.7m | $1.1b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.